Ethical problems of evaluating a new treatment for melioidosis

Allen C. Cheng; Michael Lowe; Dianne P. Stephens; Bart J. Currie

doi:10.1136/bmj.327.7426.1280

Ethical problems of evaluating a new treatment for melioidosis

Allen C. Cheng, Michael Lowe, Dianne P. Stephens, Bart J. Currie

Research output: Contribution to journal › Review article › peer-review

8 Citations (Scopus)

Abstract

When mortality from melioidosis fell sharply after multiple changes in management at an Australian hospital, doctors wanted to identify whether a new drug was responsible. But designing a trial that was ethically acceptable proved impossible.

Original language	English
Pages (from-to)	1280-1282
Number of pages	3
Journal	British Medical Journal
Volume	327
Issue number	7426
DOIs	https://doi.org/10.1136/bmj.327.7426.1280
Publication status	Published - 29 Nov 2003

Access to Document

10.1136/bmj.327.7426.1280

Cite this

@article{0a7b8086af064bb2b70cc0cc904810d8,

title = "Ethical problems of evaluating a new treatment for melioidosis",

abstract = "When mortality from melioidosis fell sharply after multiple changes in management at an Australian hospital, doctors wanted to identify whether a new drug was responsible. But designing a trial that was ethically acceptable proved impossible.",

author = "Cheng, \{Allen C.\} and Michael Lowe and Stephens, \{Dianne P.\} and Currie, \{Bart J.\}",

year = "2003",

month = nov,

day = "29",

doi = "10.1136/bmj.327.7426.1280",

language = "English",

volume = "327",

pages = "1280--1282",

journal = "British Medical Journal",

issn = "0959-8146",

publisher = "British Medical Journal Publishing Group (BMJ Publishing)",

number = "7426",

}

TY - JOUR

T1 - Ethical problems of evaluating a new treatment for melioidosis

AU - Cheng, Allen C.

AU - Lowe, Michael

AU - Stephens, Dianne P.

AU - Currie, Bart J.

PY - 2003/11/29

Y1 - 2003/11/29

N2 - When mortality from melioidosis fell sharply after multiple changes in management at an Australian hospital, doctors wanted to identify whether a new drug was responsible. But designing a trial that was ethically acceptable proved impossible.

AB - When mortality from melioidosis fell sharply after multiple changes in management at an Australian hospital, doctors wanted to identify whether a new drug was responsible. But designing a trial that was ethically acceptable proved impossible.

UR - http://www.scopus.com/inward/record.url?scp=0345687931&partnerID=8YFLogxK

U2 - 10.1136/bmj.327.7426.1280

DO - 10.1136/bmj.327.7426.1280

M3 - Review article

C2 - 14644975

AN - SCOPUS:0345687931

SN - 0959-8146

VL - 327

SP - 1280

EP - 1282

JO - British Medical Journal

JF - British Medical Journal

IS - 7426

ER -

Ethical problems of evaluating a new treatment for melioidosis

Abstract

Access to Document

Other files and links

Fingerprint

Cite this